Cargando…
Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study
BACKGROUND: Low circulating concentrations of 25-hydroxyvitamin D (25[OH]D), a marker of vitamin D status, are associated with an increased risk of type 2 diabetes, but whether this association is causal remains unclear. We aimed to estimate the unconfounded, causal association between 25(OH)D conce...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Lancet, Diabetes & Endocrinology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286815/ https://www.ncbi.nlm.nih.gov/pubmed/25281353 http://dx.doi.org/10.1016/S2213-8587(14)70184-6 |
_version_ | 1782351711154733056 |
---|---|
author | Ye, Zheng Sharp, Stephen J Burgess, Stephen Scott, Robert A Imamura, Fumiaki Langenberg, Claudia Wareham, Nicholas J Forouhi, Nita G |
author_facet | Ye, Zheng Sharp, Stephen J Burgess, Stephen Scott, Robert A Imamura, Fumiaki Langenberg, Claudia Wareham, Nicholas J Forouhi, Nita G |
author_sort | Ye, Zheng |
collection | PubMed |
description | BACKGROUND: Low circulating concentrations of 25-hydroxyvitamin D (25[OH]D), a marker of vitamin D status, are associated with an increased risk of type 2 diabetes, but whether this association is causal remains unclear. We aimed to estimate the unconfounded, causal association between 25(OH)D concentration and risk of type 2 diabetes using a mendelian randomisation approach. METHODS: Using several data sources from populations of European descent, including type 2 diabetes cases and non-cases, we did a mendelian randomisation analysis using single nucleotide polymorphisms (SNPs) within or near four genes related to 25(OH)D synthesis and metabolism: DHCR7 (related to vitamin D synthesis), CYP2R1 (hepatic 25-hydroxylation), DBP (also known as GC; transport), and CYP24A1 (catabolism). We assessed each SNP for an association with circulating 25(OH)D concentration (5449 non-cases; two studies), risk of type 2 diabetes (28 144 cases, 76 344 non-cases; five studies), and glycaemic traits (concentrations of fasting glucose, 2-h glucose, fasting insulin, and HbA(1c); 46 368 non-cases; study consortium). We combined these associations in a likelihood-based mendelian randomisation analysis to estimate the causal association of 25(OH)D concentration with type 2 diabetes and the glycaemic traits, and compared them with that from a meta-analysis of data from observational studies (8492 cases, 89 698 non-cases; 22 studies) that assessed the association between 25(OH)D concentration and type 2 diabetes. FINDINGS: All four SNPs were associated with 25(OH)D concentrations (p<10(−6)). The mendelian randomisation-derived unconfounded odds ratio for type 2 diabetes was 1·01 (95% CI 0·75–1·36; p=0·94) per 25·0 nmol/L (1 SD) lower 25(OH)D concentration. The corresponding (potentially confounded) relative risk from the meta-analysis of data from observational studies was 1·21 (1·16–1·27; p=7·3 × 10(−19)). The mendelian randomisation-derived estimates for glycaemic traits were not significant (p>0·25). INTERPRETATION: The association between 25(OH)D concentration and type 2 diabetes is unlikely to be causal. Efforts to increase 25(OH)D concentrations might not reduce the risk of type 2 diabetes as would be expected on the basis of observational evidence. These findings warrant further investigations to identify causal factors that might increase 25(OH)D concentration and also reduce the risk of type 2 diabetes. FUNDING: UK Medical Research Council Epidemiology Unit and European Union Sixth Framework Programme. |
format | Online Article Text |
id | pubmed-4286815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | The Lancet, Diabetes & Endocrinology |
record_format | MEDLINE/PubMed |
spelling | pubmed-42868152015-01-13 Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study Ye, Zheng Sharp, Stephen J Burgess, Stephen Scott, Robert A Imamura, Fumiaki Langenberg, Claudia Wareham, Nicholas J Forouhi, Nita G Lancet Diabetes Endocrinol Articles BACKGROUND: Low circulating concentrations of 25-hydroxyvitamin D (25[OH]D), a marker of vitamin D status, are associated with an increased risk of type 2 diabetes, but whether this association is causal remains unclear. We aimed to estimate the unconfounded, causal association between 25(OH)D concentration and risk of type 2 diabetes using a mendelian randomisation approach. METHODS: Using several data sources from populations of European descent, including type 2 diabetes cases and non-cases, we did a mendelian randomisation analysis using single nucleotide polymorphisms (SNPs) within or near four genes related to 25(OH)D synthesis and metabolism: DHCR7 (related to vitamin D synthesis), CYP2R1 (hepatic 25-hydroxylation), DBP (also known as GC; transport), and CYP24A1 (catabolism). We assessed each SNP for an association with circulating 25(OH)D concentration (5449 non-cases; two studies), risk of type 2 diabetes (28 144 cases, 76 344 non-cases; five studies), and glycaemic traits (concentrations of fasting glucose, 2-h glucose, fasting insulin, and HbA(1c); 46 368 non-cases; study consortium). We combined these associations in a likelihood-based mendelian randomisation analysis to estimate the causal association of 25(OH)D concentration with type 2 diabetes and the glycaemic traits, and compared them with that from a meta-analysis of data from observational studies (8492 cases, 89 698 non-cases; 22 studies) that assessed the association between 25(OH)D concentration and type 2 diabetes. FINDINGS: All four SNPs were associated with 25(OH)D concentrations (p<10(−6)). The mendelian randomisation-derived unconfounded odds ratio for type 2 diabetes was 1·01 (95% CI 0·75–1·36; p=0·94) per 25·0 nmol/L (1 SD) lower 25(OH)D concentration. The corresponding (potentially confounded) relative risk from the meta-analysis of data from observational studies was 1·21 (1·16–1·27; p=7·3 × 10(−19)). The mendelian randomisation-derived estimates for glycaemic traits were not significant (p>0·25). INTERPRETATION: The association between 25(OH)D concentration and type 2 diabetes is unlikely to be causal. Efforts to increase 25(OH)D concentrations might not reduce the risk of type 2 diabetes as would be expected on the basis of observational evidence. These findings warrant further investigations to identify causal factors that might increase 25(OH)D concentration and also reduce the risk of type 2 diabetes. FUNDING: UK Medical Research Council Epidemiology Unit and European Union Sixth Framework Programme. The Lancet, Diabetes & Endocrinology 2015-01 /pmc/articles/PMC4286815/ /pubmed/25281353 http://dx.doi.org/10.1016/S2213-8587(14)70184-6 Text en © 2015 Ye et al. Open Access article distributed under the terms of CC BY https://creativecommons.org/licenses/by/3.0/This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Articles Ye, Zheng Sharp, Stephen J Burgess, Stephen Scott, Robert A Imamura, Fumiaki Langenberg, Claudia Wareham, Nicholas J Forouhi, Nita G Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study |
title | Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study |
title_full | Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study |
title_fullStr | Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study |
title_full_unstemmed | Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study |
title_short | Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study |
title_sort | association between circulating 25-hydroxyvitamin d and incident type 2 diabetes: a mendelian randomisation study |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286815/ https://www.ncbi.nlm.nih.gov/pubmed/25281353 http://dx.doi.org/10.1016/S2213-8587(14)70184-6 |
work_keys_str_mv | AT yezheng associationbetweencirculating25hydroxyvitamindandincidenttype2diabetesamendelianrandomisationstudy AT sharpstephenj associationbetweencirculating25hydroxyvitamindandincidenttype2diabetesamendelianrandomisationstudy AT burgessstephen associationbetweencirculating25hydroxyvitamindandincidenttype2diabetesamendelianrandomisationstudy AT scottroberta associationbetweencirculating25hydroxyvitamindandincidenttype2diabetesamendelianrandomisationstudy AT imamurafumiaki associationbetweencirculating25hydroxyvitamindandincidenttype2diabetesamendelianrandomisationstudy AT associationbetweencirculating25hydroxyvitamindandincidenttype2diabetesamendelianrandomisationstudy AT langenbergclaudia associationbetweencirculating25hydroxyvitamindandincidenttype2diabetesamendelianrandomisationstudy AT warehamnicholasj associationbetweencirculating25hydroxyvitamindandincidenttype2diabetesamendelianrandomisationstudy AT forouhinitag associationbetweencirculating25hydroxyvitamindandincidenttype2diabetesamendelianrandomisationstudy |